Find a TenderClosedTender notice
Published 16 Jul 2025, 16:24 BST

Official UK procurement notice

Framework Agreement for the Supply, Maintenance & Consumables for Multi-Apheresis and ECP Systems

Official notice

Authority: NHS Blood and Transplant (Central government)

Open framework scheme2 lotsGoodsCompetitive flexible procedureAbove threshold
Framework ceiling (notional)£49,800,000total for 2 lots · framework ceiling, not attributable revenue · 1 value update
Submissions closed 17 Aug 2026
Lots 2see the lot list below
Framework period 8 yrsends 31 Jan 2035 · starts 1 Feb 2027

What is being bought2 lots · detail below

Published requirement description

NHS Blood and Transplant (NHSBT) is a Special Health Authority and is responsible for the provision of blood components and a range of associated laboratory and patient therapeutic services to hospitals.

The NHSBT Therapeutic Apheresis Service (TAS) provide lifesaving and life-enhancing therapies to adults and children across a range of clinical specialties. Patients receive treatment either at their hospital bedside or where clinically appropriate as an outpatient in an NHS Blood and Transplant (NHSBT) unit. NHSBT provides regional access to apheresis services from 10 dedicated units across England and Wales (Bristol, London, Oxford, Leeds, Sheffield, Liverpool, Manchester, Birmingham, Plymouth, Cambridge and Liverpool) with each unit led by a team of specialist medical and nursing staff.

NHSBT are tendering for the establishment of an Open Framework for the purchase of therapeutic apheresis machines, consumables and maintenance, to support provision of new Therapeutic Apheresis Systems for Extracorporeal Photopheresis (ECP), Apheresis Collection, Exchange and Depletion Procedures (including Bone Marrow), and associated consumables and maintenance.

  • The authority expects to re-tender this requirement around 1 Jan 2027, 23:59 GMT.
  • How the procedure runs: This Procurement is being run under a Competitive Flexible Procedure pursuant to section 20(2)(b) of the Procurement Act 2023 to establish a Framework Agreement. All tenders who submit a compliant tender and meet the mandatory Conditions of Participation will be appointed to the Framework Agreement. The Authority intends to follow a two-stage process as outlined below. The Authority reserves the right to amend the process (including the number of stages or re-running any stage) where necessary and any changes will be communicated promptly. Tender Stage 1: • Publish tender notice and tender documents • Receive tenders • Assess tenders to shortlist those to be invited to Stage 2 (if appropriate) • Notify shortlisted suppliers and invite to Stage 2 (if appropriate) Tender Stage 2 (if required): • Clarifications Award Stage: • Notify suppliers and issue assessment summaries • Publish contract award notice and commence standstill period • Award Framework Agreement • Publish Contract Details Notice • Undertake Validation Conditions of Participation (via the Procurement Specific Questionnaire) will be applied to ensure that tenderers meet minimum requirements. Failure to meet these requirements will result in exclusion from further evaluation. Further information can be found in the tender documents.

CPV: Medical equipments

How this framework works

From the published notice
Type
Closed framework · open framework scheme (admission reopens)
Call-offs
call-offs may be awarded directly or by further competition
Framework period
8 yrs from 1 Feb 2027
Scheme runs until
31 Jan 2035
Published description of the framework

The Authority intends to establish a multi-supplier Open Framework Agreement. Suppliers awarded to the Framework will be ranked by Lot based on the outcome of the tender evaluation. Call-off contracts may be awarded by direct award to the highest-ranked Supplier capable of meeting the Authority's requirements. Where the highest-ranked Supplier is unable to meet the requirement, the Authority may approach the next ranked Supplier. The Authority reserves the right to conduct a further competition between Framework Suppliers where this is considered necessary to achieve best value. The Open Framework may be reopened during its term in accordance with the Procurement Act 2023.

Lots and requirements (2)Procurement structure

2 lots · all with a published value · same evaluation weights on every lot
Lot #1Multi-Apheresis Systems 8 yrsPublished value£26,800,000

Supply, Maintenance and Consumables of White Cell Depletion (WCD) and Platelet Depletion (PD) Multi Apheresis Systems

Contract period: 1 Feb 2027 – 31 Jan 2035 (8 yrs)Value: £26,800,000 exc. VAT · £32,160,000 inc. VAT
Lot #2ECP Systems 8 yrsPublished value£20,600,000

Supply, Maintenance and Consumables Extracorporeal Photopheresis (ECP) systems used in Therapeutic Apheresis Services

Contract period: 1 Feb 2027 – 31 Jan 2035 (8 yrs)Value: £20,600,000 exc. VAT · £24,720,000 inc. VAT

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
How bids were scored · same split on all 2 lots
Quality: 60%Price: 30%Social value: 10%
Published sub-criteria (3)
  • Technical / Quality: 60%
  • Price: 30%
  • Social Value: 10%
Published award criteria (3)
  • Price
  • Technical / Quality
  • Social Value
What this means for your bid
  • Price carries 30 of 100 points: a 10% discount moves about 3 points. The method statement decides this lot, not the discount.
  • “Framework Agreement for the Supply, Maintenance & Consumables for…” is a framework: the contest is a place on its panel, not a single contract: call-offs may be direct or by further competition.

Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.

Procedure terms & legal framework

From the official record
Procedure method
Competitive flexible procedure
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Procurement category
Goods
Notice status
Closed
Procurement threshold
Above threshold (FTS publication)
Regulatory regime
Standard
Commercial structure
Open framework scheme
Who may use this agreement
Not stated in the notice; call-off rights may be limited to the establishing authority
Competition type
Competitive procedure
GPA / WTO covered
Unspecified in notice
Recurring procurement
Yes · next expected 1 Jan 2027
First published
16 Jul 2025, 16:24 BST
Last source update
14 Jul 2026, 17:15 BST
Award evaluation window
Submission end – 1 Jan 2027
Authority reference
C376077
FTS notice number
2026/S 000-066470
Latest notice
Tender notice (UK4)
Classification (CPV)
Medical equipments
Delivery area
North East (UKC)North West (UKD)East Midlands (UKF)West Midlands (UKG)East of England (UKH)South East (UKJ)South West (UKK)
Official registry OCID
ocds-h6vhtk-0560a1 Find a Tender
How it runs

This Procurement is being run under a Competitive Flexible Procedure pursuant to section 20(2)(b) of the Procurement Act 2023 to establish a Framework Agreement. All tenders who submit a compliant tender and meet the mandatory Conditions of Participation will be appointed to the Framework Agreement.

The Authority intends to follow a two-stage process as outlined below. The Authority reserves the right to amend the process (including the number of stages or re-running any stage) where necessary and any changes will be communicated promptly.

Tender Stage 1:

  • Publish tender notice and tender documents
  • Receive tenders
  • Assess tenders to shortlist those to be invited to Stage 2 (if appropriate)
  • Notify shortlisted suppliers and invite to Stage 2 (if appropriate)

Tender Stage 2 (if required):

  • Clarifications

Award Stage:

  • Notify suppliers and issue assessment summaries
  • Publish contract award notice and commence standstill period
  • Award Framework Agreement
  • Publish Contract Details Notice
  • Undertake Validation

Conditions of Participation (via the Procurement Specific Questionnaire) will be applied to ensure that tenderers meet minimum requirements. Failure to meet these requirements will result in exclusion from further evaluation.

Further information can be found in the tender documents.

Review and risk notes
Risks

Unforeseen Regulatory Changes for NHS Blood and Transplant or the Supplier (or principal Subcontractors) which may impact volume or type of activity.

Unforeseen increase in activity which may impact volume or type of activity.

How it was run

Official notice
Run through: Atamis legacy domain (health-family.force.com) · Who buys & how to bid on Atamis
Supplier login requiredElectronic submission allowedLanguage: EN
Access & registration note: Legacy Salesforce domain still used in notices — use the current Atamis portal · this portal address is a legacy domain; the operator has migrated
Appointment period ends
17 Aug 2026, 12:00 BST
Clarification deadline
10 Aug 2026, 12:00 BST
Submission channel
Official e-sourcing portal
Electronic submission
Allowed
Accepted languages
en
Detailed submission instructions & authority contactsFrom official release

Timeline

16 Jul 2025 → 1 Feb 2027 · 8 dates
  1. Planning notice published
    16 Jul 2025, 16:24 BST
  2. Market engagement
    18 Aug 2025, 23:59 BST

    NHSBT wishes to invite those organisations who express an interest in this opportunity to Supplier engagement meetings to be held during September 2025. Any interested organisations are asked to contact rowena.thomas@nhsbt.nhs.uk by no later than 17:00 on the 18th August 2025 to express their interest. If you do not respond by this date, you are not excluded from participating in the forthcoming tender, this date is to allow for optional supplier engagement meetings to be organised. There is no guarantee that a formal procurement process will be launched as a result of this early market engagement exercise, nor that any contract(s) will be placed. No remuneration or compensation etc will be paid to organisations who take part in this early market engagement exercise. Suppliers should take part in this process only on the basis that they fully understand and accept this position. Further information e.g. draft technical specification, award criteria, timescales, may be released for consultation purposes only, to organisations who express an interest in this notice. Please note that all details are subject to change.

  3. Next notice expected240 days ago
    1 Mar 2026, 23:59 GMT
  4. Tender notice published105 days ago
    14 Jul 2026, 17:15 BST
  5. Clarification questions by79 days ago
    10 Aug 2026, 12:00 BST
  6. Admission / appointment period ends72 days ago · period end, not a bid countdown
    17 Aug 2026, 12:00 BST
  7. Today
    28 Oct 2026
  8. Award decision expected byin 65 days
    1 Jan 2027, 23:59 GMT
  9. Contract startsin 95 days
    1 Feb 2027

Notice history

6 events · 2 releases on Find a Tender · since 16 Jul 2025
  1. Preliminary market engagement notice published
    16 Jul 2025, 16:24 BST
    UK2
  2. Tender notice published
    14 Jul 2026, 17:15 BST
    UK4
  3. Published value updated to £49,800,000
    14 Jul 2026, 17:15 BST
    was £65,000,000
  4. Status changed to active
    14 Jul 2026, 17:15 BST
  5. Procurement method changed
    14 Jul 2026, 17:15 BST
  6. Deadline published: 17 Aug 2026, 12:00 BST
    14 Jul 2026, 17:15 BST

Contracting authority & participating public bodies

NHS Blood and Transplant

Contracting authorityPublic authority - central government GB-PPON: PDBY-6395-VWBP 500 North Bristol Park, Bristol, South West, BS34 7QHContact name, email, phone

Official documents & specifications (2)

Official links; attachments are not copied

Notices published for this procedure